• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Biotech

Graphic images of white and black puzzle pieces connecting seamlessly
Biotech

Eli Lilly taps Camurus' tech to advance long-acting obesity meds

With the deal, Lilly can use Camurus' long-acting delivery technology on up to four of its own incretin compounds.
Zoey Becker Jun 3, 2025 5:04pm
workers

Fierce Biotech Layoff Tracker 2025: Plexium, Keros & more

Jun 3, 2025 4:30pm
Precision medicines next frontier unlocking the power of biospecimens
Sponsored

Unlocking the power of biospecimens

Jun 2, 2025 8:00am
Pencil eraser erasing drawn human figure

Plexium cuts staff, realigns resources to support pipeline

Jun 3, 2025 4:12pm
Forging the future of cell therapy Bayer and BlueRocks unique journey
Sponsored

Forging the future of cell therapy: Bayer and BlueRock’s unique journey

Jun 2, 2025 8:00am
bumpy road rough bad path

BioAge inks option agreement for Chinese biotech's obesity asset

Jun 3, 2025 2:06pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings